Long-term effect of rituximab in anti-mag polyneuropathy

Neurology. 2008 Nov 18;71(21):1742-4. doi: 10.1212/01.wnl.0000335268.70325.33.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin M / blood*
  • Immunologic Factors / therapeutic use
  • Male
  • Middle Aged
  • Myelin-Associated Glycoprotein / immunology*
  • Polyneuropathies / blood
  • Polyneuropathies / drug therapy*
  • Polyneuropathies / immunology
  • Rituximab
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin M
  • Immunologic Factors
  • Myelin-Associated Glycoprotein
  • Rituximab